Elective endovascular repair of abdominal aortic aneurysms in elderly with Endologix AFX® endograft: Our short-term and one-year results

Abstract

Objectives: In this study, we aimed to evaluate the performance of Endologix AFX® endografts in elderly in the early period and in the first postoperative year. Patients and methods: Between January 2012 and December 2017, a total of 63 consecutive patients (60 males, 3 females; mean age 68.2±7.2 years; range, 52 to 84 years) with an infrarenal abdominal aortic aneurysm (AAA) were operated using endovascular aneurysm repair (EVAR) with an Endologix AFX® endograft in an elective fashion. The patients were divided into two groups as those aged under 70 years (n=35) and over 70 years of age (n=28). Results: The most associated comorbidities were hypertension (63.5%), coronary artery disease (57.1%), and chronic obstructive pulmonary disease (38.1%). There was no 30-day mortality and no renal or cardiac morbidity in the early postoperative period. The mean length of intensive care unit stay was 9±6.4 h and the mean length of hospital stay was 3±1.4 days, indicating no statistically significant difference between the groups. Conclusion: Our study results suggest that the Endologix AFX® endograft can yield successful outcomes in the early and postoperative first year, irrespective of the age of the patient. [Turk J Vasc Surg 2019; 28(1.000): 36-41]

Keywords

• early mortality; elderly patients; endologix afx endograft; endovascular aneurysm repair